arrow
R

Ricardo Menegatti

federal university of goias
H指数:19
被引数:1,360

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Characterization of a novel small chemical entity with anxiolytic- and antidepressant-like effects targeting multiple receptors

一种新型小分子化学实体的表征,该实体具有抗焦虑和抗抑郁样作用,并靶向多种受体

2025-10-230
PRE
Antileishmanial, cytotoxic activities, and membrane rigidity effects of three synthetic compounds

抗利什曼原虫活性、细胞毒性活性以及三种合成化合物的膜刚性效应

2025-09-080
PRE
Anti-inflammatory and antinociceptive effects of LQFM275-A new multi-target drug

LQFM275的抗炎和镇痛作用——一种新型多靶点药物

2025-01-010
PRE
Glycosylation of chrysin with β-d-glucose tetraacetate (LQFM280) enhances its in vitro and in vivo neuroprotective effects against the toxicity induced by 3-nitropropionic acid
2024-10-160
PRE
Novel Proline Transporter Inhibitor (LQFM215) Presents Antipsychotic Effect in Ketamine Model of Schizophrenia
2023-09-091
PRE
Preclinical data on morpholine (3,5-di-tertbutyl-4-hydroxyphenyl) methanone induced anxiolysis
2023-04-252
PRE
Electrochemical Characterization of Central Action Tricyclic Drugs by Voltammetric Techniques and Density Functional Theory Calculations
2019-08-0110
OAAI
Novel choline analog 2-(4-((1-phenyl-1H-pyrazol-4-yl)methyl)piperazin-1-yl)ethan-1-ol produces sympathoinhibition, hypotension, and antihypertensive effects
2019-05-024
PREAI
Tert-butyl 4-((1-phenyl-1H-pyrazol-4-yl) methyl) piperazine-1-carboxylate (LQFM104)- New piperazine derivative with antianxiety and antidepressant-like effects: Putative role of serotonergic system
2018-07-0122
PREAI